Raj G Vaghjiani - JoVE Visualize

Showing results (1-10 of 9) with videos related to

Pageof 1

Sort By:

Chinese Clinical Oncology|November 14, 2017

Surgical management of esophageal cancerRaj G Vaghjiani, Daniela Molena

Cancers|August 12, 2022

Tertiary Lymphoid Structures as Mediators of Immunotherapy ResponseRaj G Vaghjiani, Joseph J Skitzki

Immunotherapy|January 18, 2018

Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapyHua Zheng, Masha Zeltsman, Marjorie G Zauderer, et al.

Lung Cancer (Amsterdam, Netherlands)|November 20, 2019

Decreasing use of epidural analgesia with increasing minimally invasive lobectomy: Impact on postoperative morbidityMasha Zeltsman, Jordan Dozier, Raj G Vaghjiani, et al.

Oncotarget|December 6, 2018

Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillanceYusuke Takahashi, Takashi Eguchi, Koji Kameda, et al.

Annals of Palliative Medicine|November 7, 2015

American College of Surgeons National Surgical Quality Improvement Program as a quality-measurement tool for advanced cancer patientsRoberto J Vidri, Andrew M Blakely, Shreyus S Kulkarni, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 3, 2020

Tumor Spread Through Air Spaces Is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung AdenocarcinomaRaj G Vaghjiani, Yusuke Takahashi, Takashi Eguchi, et al.

Journal for Immunotherapy of Cancer|June 22, 2023

Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinomaDavid Restle, Joseph Dux, Xiaoyu Li, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 11, 2021

Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung AdenocarcinomaDaniel J Gross, Navin K Chintala, Raj G Vaghjiani, et al.

Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:

Pageof 1

Chinese Clinical Oncology|November 14, 2017

Surgical management of esophageal cancerRaj G Vaghjiani, Daniela Molena

Cancers|August 12, 2022

Tertiary Lymphoid Structures as Mediators of Immunotherapy ResponseRaj G Vaghjiani, Joseph J Skitzki

Immunotherapy|January 18, 2018

Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapyHua Zheng, Masha Zeltsman, Marjorie G Zauderer, et al.

Lung Cancer (Amsterdam, Netherlands)|November 20, 2019

Decreasing use of epidural analgesia with increasing minimally invasive lobectomy: Impact on postoperative morbidityMasha Zeltsman, Jordan Dozier, Raj G Vaghjiani, et al.

Oncotarget|December 6, 2018

Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillanceYusuke Takahashi, Takashi Eguchi, Koji Kameda, et al.

Annals of Palliative Medicine|November 7, 2015

American College of Surgeons National Surgical Quality Improvement Program as a quality-measurement tool for advanced cancer patientsRoberto J Vidri, Andrew M Blakely, Shreyus S Kulkarni, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 3, 2020

Tumor Spread Through Air Spaces Is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung AdenocarcinomaRaj G Vaghjiani, Yusuke Takahashi, Takashi Eguchi, et al.

Journal for Immunotherapy of Cancer|June 22, 2023

Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinomaDavid Restle, Joseph Dux, Xiaoyu Li, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 11, 2021

Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung AdenocarcinomaDaniel J Gross, Navin K Chintala, Raj G Vaghjiani, et al.

Pageof 1